These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7108595)

  • 81. 31P magnetic resonance spectroscopy is sensitive to tumor hypoxia: perfusion and oxygenation of rat 9L gliosarcoma after treatment with BCNU.
    Steen RG; Graham MM
    NMR Biomed; 1991 Jun; 4(3):117-24. PubMed ID: 1911098
    [TBL] [Abstract][Full Text] [Related]  

  • 82. BCNU and steroids in the viral-induced dog brain tumor.
    Brisman R; Schlesinger EB; Willson N; Hilal S; Michelsen JW; Gamboa E; Goldberg N
    Neurol Res; 1979; 1(2):147-57. PubMed ID: 233267
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Therapy of malignant brain tumors: comparison of the in vitro activities of vidarabin-monophosphate, BCNU and 5-fluorouracil.
    Bogdahn U; Weber H; Zapf J; Dünisch G; Löbering HG; Mertens HG
    Acta Neurol Scand; 1987 Jan; 75(1):28-36. PubMed ID: 3577665
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Combination of perfluorochemical emulsions and carbogen breathing with cancer chemotherapy.
    Teicher BA
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1109-20. PubMed ID: 7849913
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Chemotherapy studies in autochthonous rat tumors: carcinomas of the forestomach.
    Habs M; Schmähl D
    J Cancer Res Clin Oncol; 1979 Sep; 95(1):39-42. PubMed ID: 91617
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Brain tumor therapy: prospects for combining BCNU with conventional radiotherapy schedules.
    Wheeler KT; Kaufman K
    Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1065-8. PubMed ID: 7298401
    [No Abstract]   [Full Text] [Related]  

  • 87. Effect of combined surgery and BCNU (NSC-409962) on an animal brain tumor model.
    Tel E; Barker M; Levin VA; Wilson CB
    Cancer Chemother Rep; 1974; 58(5 Pt 1):627-31. PubMed ID: 4473264
    [No Abstract]   [Full Text] [Related]  

  • 88. Post-treatment kinetics of BCNU in a 9L rat brain tumor model.
    Nomura K; Hoshino T; Pentecost SM
    Neurol Med Chir (Tokyo); 1981 Jan; 21(1):19-25. PubMed ID: 6168947
    [No Abstract]   [Full Text] [Related]  

  • 89. In vivo delivery of BCNU from a MEMS device to a tumor model.
    Li Y; Ho Duc HL; Tyler B; Williams T; Tupper M; Langer R; Brem H; Cima MJ
    J Control Release; 2005 Aug; 106(1-2):138-45. PubMed ID: 16167384
    [TBL] [Abstract][Full Text] [Related]  

  • 90. An experimental model for meningeal leukemia in rats (L5222). Effect of treatment with BCNU and cyclophosphamide.
    Fiebig HH; Zeller WH; Schmähl D
    Int J Cancer; 1976 Nov; 18(5):710-6. PubMed ID: 992902
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cure of advanced L1210 leukemia after correction of abnormal red blood cell deformability.
    Cohen MH
    Cancer Chemother Pharmacol; 1981; 5(3):175-9. PubMed ID: 7296752
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Perturbation of cell kinetics on 9L rat brain tumor treated with BCNU, in vitro and in vivo (author's transl)].
    Nomura K; Hoshino T
    Neurol Med Chir (Tokyo); 1978 Sep; 18(7 Pt 2):551-7. PubMed ID: 82218
    [No Abstract]   [Full Text] [Related]  

  • 93. Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study.
    Ross BD; Zhao YJ; Neal ER; Stegman LD; Ercolani M; Ben-Yoseph O; Chenevert TL
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7012-7. PubMed ID: 9618530
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Effect of perfluorochemicals on radiation therapy in a 9L rat glioma tumor model].
    Korosue K; Kokunai T; Kuwamura K; Tamaki N; Matsumoto S
    Neurol Med Chir (Tokyo); 1984 Apr; 24(4):227-32. PubMed ID: 6205306
    [No Abstract]   [Full Text] [Related]  

  • 95. [Scheduled combination chemotherapy of adriamycin and BCNU to malignant brain tumors (author's transl)].
    Kohno T; Matsutani M; Hoshino T; Sano K; Shitara N
    Neurol Med Chir (Tokyo); 1976 Nov; 16(6 Pt 2):545-53. PubMed ID: 64946
    [No Abstract]   [Full Text] [Related]  

  • 96. Immune adjuvants for chemotherapy or radiotherapy in the 9L rat brain tumor model.
    Liu C; Kimler BF; Evans RG; Morantz RA
    J Neurooncol; 1993 Feb; 15(2):113-23. PubMed ID: 8509816
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Inhibition of bcl-2 and cox-2 Protein Expression after Local Application of a New Carmustine-Loaded Clinoptilolite-Based Delivery System in a Chemically Induced Skin Cancer Model in Mice.
    Ghiciuc CM; Strat AL; Ochiuz L; Lupusoru CE; Ignat M; Vasile A; Grigorovici A; Stoleriu I; Solcan C
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29156646
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Influence of fractionation schedules on the response of a rat brain tumor to therapy with BCNU and radiation.
    Wheeler KT; Kaufman K
    Int J Radiat Oncol Biol Phys; 1980 Jul; 6(7):845-9. PubMed ID: 7204120
    [No Abstract]   [Full Text] [Related]  

  • 99. Pharmacokinetics of 11C-BCNU in experimental brain tumor.
    Sako K; Diksic M; Farrokhzad S; Yamamoto YL; Feindel W
    J Neurooncol; 1985; 3(3):229-35. PubMed ID: 4056852
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Potentials and possible pitfalls of human stem cell analysis.
    Rosenblum ML; Dougherty DV; Reese C; Wilson CB
    Cancer Chemother Pharmacol; 1981; 6(3):227-35. PubMed ID: 7318145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.